Skip to main content

Table 5 Reported versus actual sedative and analgesic agent use

From: National survey and point prevalence study of sedation practice in UK critical care

Point prevalence study First-choice sedative agent reported in national survey
Propofol Midazolam
Patients who received any sedative agenta, n 170 18
Patients who received unit’s first-choice sedative agent, n (%) 149 (87.6) 6 (33.3)
Percentage of patients who received first-choice sedative across unitsb, median (IQR) 100 (64–100)
Point prevalence study First-choice analgesic agent reported in national surveyc
Alfentanil Fentanyl Remifentanil Morphine
Patients who received any analgesic agentd, n 75 61 22 28
Patients who received unit’s first-choice analgesic agent, n (%) 58 (77.3) 57 (93.4) 12 (54.5) 15 (53.4)
Percentage of patients who received first-choice analgesic across unitse, median (IQR) 80 (67–100)
  1. a In critical care units reporting in the national survey that they use the indicated sedative agent as their first choice
  2. b Excluding units with fewer than three eligible patients (n = 23)
  3. c Ten patients in two units that reported using two alternative analgesic agents as their first choice are excluded from data for individual agents but included in summary data across units (where either of the two indicated agents may have been used)
  4. d In critical care units reporting in the national survey that they use the indicated analgesic agent as their first choice
  5. e Excluding units with fewer than three eligible patients (n = 19)